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A B S T R A C T
Background: There are several standards that offer explicit guidance on good practice in systematic reviews
(SRs) for the medical sciences; however, no similarly comprehensive set of recommendations has been published
for SRs that focus on human health risks posed by exposure to environmental challenges, chemical or otherwise.
Objectives: To develop an expert, cross-sector consensus view on a key set of recommended practices for the
planning and conduct of SRs in the environmental health sciences.
Methods: A draft set of recommendations was derived from two existing standards for SRs in biomedicine and
developed in a consensus process, which engaged international participation from government, industry, non-
government organisations, and academia. The consensus process consisted of a workshop, follow-up webinars,
email discussion and bilateral phone calls.
Results: The Conduct of Systematic Reviews in Toxicology and Environmental Health Research (COSTER) re-
commendations cover 70 SR practices across eight performance domains. Detailed explanations for specific
recommendations are made for those identified by the authors as either being novel to SR in general, specific to
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the environmental health SR context, or potentially controversial to environmental health SR stakeholders.
Discussion: COSTER provides a set of recommendations that should facilitate the production of credible, high-
value SRs of environmental health evidence, and advance discussion of a number of controversial aspects of
conduct of EH SRs. Key recommendations include the management of conflicts of interest, handling of grey
literature, and protocol registration and publication. A process for advancing from COSTER’s recommendations
to developing a formal standard for EH SRs is also indicated.
1. Introduction
In the fields of toxicology, epidemiology, environmental health and
chemical risk assessment (henceforth abbreviated as “environmental
health (EH) research”), systematic reviews (SRs) are increasingly con-
ducted (see Fig. 1) and used by academics, non-government organisa-
tions, industry and regulators to characterise health hazards and risks
posed by exposure to environmental challenges (Whaley et al., 2016).
One of the drivers of this growing interest is increasing recognition of
the potential for systematic methods to offer a new benchmark in best
practice for aggregating and summarising evidence in support of policy
decisions (EFSA, 2010; Rooney et al., 2014; NAS, 2017, 2014; Stephens
et al., 2016).
In service of this interest, there is a burgeoning number of docu-
ments which purport to provide varying types of guidance for con-
ducting SRs in EH research. These include, for example: a US agency
handbook (NTP OHAT, 2019); US and EU guidance documents
(Schaefer and Myers, 2017; EFSA, 2015; EPA, 2018); Instructions to
Authors (IARC, 2019a, 2019b); and general frameworks (Vandenberg
et al., 2016; Woodruff and Sutton, 2014).
The challenge for the reader is in how SR guidance documents vary
in their levels of comprehensiveness and detail, domains of applic-
ability, the extent to which they have been tested and validated, and
what they define (either implicitly or explicitly) as being essential SR
methodology. For example, the US National Toxicology Program Office
of Health Assessment and Translation (NTP OHAT) handbook is for SRs
conducted in support of hazard assessment within a US regulatory
framework (Rooney et al., 2014; NTP OHAT, 2019), whereas the Na-
vigation Guide Framework (Woodruff and Sutton, 2014) is intended for
a more general research context. While the Navigation Guide and NTP
OHAT approaches are largely similar (with steps including develop-
ment of a protocol, comprehensive search strategies, employment of a
Cochrane-derived risk of bias approach to appraising study quality, and
use of a GRADE-based approach to assessing confidence in a body of
evidence) there are some differences between the two. Other ap-
proaches have larger differences. For example, the SYRINA framework
(Vandenberg et al., 2016) lays out a wide range of options for SR teams
to choose from, and a draft SR-based risk assessment methodology for
the US Toxic Substances Control Act (EPA, 2018) scores study quality
rather than implementing Cochrane guidance on risk of bias assessment
(Singla et al., 2019). Others differ in their use of protocols, their ap-
proach to critical appraisal of included studies, and their methods for
assessing certainty in the evidence. Furthermore, some EH SR guidance
documents are intended to apply to the entire environmental health risk
assessment process, while others focus on a particular stage of it. Many
SR guidance documents have also been developed for specific purposes
and are not necessarily intended to represent a broader community
view of general good practice. Overall, these documents do not provide
a collectively consistent, general overview of good practice in the
planning and conduct of EH SRs.
The development and promulgation of clear, expert guidance on
good practice is considered by institutions including the US Institute of
Medicine to be an important contributor to ensuring the quality of
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Fig. 1. Chart showing annual increase in number of publications on topics related to EH research with the term “systematic review” in the title, indexed in Web of
Science. The total number of publications approximately doubled between 2016 and 2020. Search: TITLE: (“systematic review”), Refined by: WEB OF SCIENCE
CATEGORIES: (PUBLIC ENVIRONMENTAL OCCUPATIONAL HEALTH OR TOXICOLOGY) AND [excluding] WEB OF SCIENCE CATEGORIES: (PHARMACOLOGY
PHARMACY), Timespan: All years (1995–2019 shown). Indexes: SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, BKCI-S, BKCI-SSH, ESCI, CCR-EXPANDED, IC.
Date of search: 4 February 2020.
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such guidance specific to EH SRs was recognised in a 2014 expert
workshop on applying SR methods to chemical risk assessment. Among
other strategic proposals, the workshop recommended “development of
a recognised ‘gold standard’ for SRs in toxicology and risk assessment
[…] to address the growing number of purported SRs of unclear validity
which are increasingly prevalent in the environmental health litera-
ture” (Whaley et al., 2016).
A broad cross-section of relevant stakeholders was therefore con-
vened, with the objective of developing a comprehensive set of re-
commendations for the planning and conduct of SRs in EH research.
These recommendations are based on standard practices and processes
for conduct of SRs in other fields, and put forward to initiate broader
discussion as to what the EH community’s collective expectations for SR
methods ought to be.
2. Methods
A workshop was held on 2 December 2016, attended by 31 parti-
cipants from academic, policy, regulatory, non-government and in-
dustry backgrounds (see Supplemental Information 01). Participants
were prioritised for invitation to the workshop from an initial longlist of
62 drawn up by PW and CH, based on a mixture of having a publishing
history demonstrating at least some experience in systematic review or
the principles thereof, professional reputation, economic sector, and
word-of-mouth recommendation. An overall balance of expertise in SR,
weight-of-evidence methods, chemical risk assessment, toxicology,
epidemiology, environmental health research and chemicals policy was
sought across the final group of participants, along with balanced re-
presentation from each stakeholder group including a target of at least
two NGO participants. Lancaster University provided £5000 to facilitate
balanced participation, covering travel costs for participants who would
not otherwise be able to attend the workshop.
The recommendations for good practice were developed using a
consensus methodology. “Consensus” was defined following the ter-
minology of the International Organization for Standardization (ISO) as
“general agreement, characterized by the absence of sustained opposi-
tion to substantial issues by any important part of the concerned in-
terests and by a process that involves seeking to take into account the
views of all parties concerned and to reconcile any conflicting argu-
ments” (ISO/IEC, 2004).
The consensus process was seeded by two discussion documents
drafted by PW (see Supplements 02 and 03). A draft set of re-
commendations (Supplement 03), initially given the working title of
“ECOSYS-CRA” before being renamed “COSTER”, was created by
combining version 2.3 of the Cochrane MECIR standards (Chandler
et al., 2013) with the US Institute of Medicine What Works in Health
Care: Standards for Systematic Reviews (Eden et al., 2011), henceforth
referred to as “MECIR” and “IOM” respectively. The MECIR and IOM
standards were taken to already represent a high degree of consensus
and expectation of effectiveness of sound-practice requirements relating
to general SR methods in biomedicine, thereby providing a solid basis
for interpretation into a set of recommendations for EH SRs.
The draft recommendations were discussed element-by-element at
the workshop by two break-out groups working in parallel, chaired by
PW and JL. Feedback was solicited on four areas. (a) Which of the
proposed elements would constitute “sound and good practice” for EH
SRs, and should therefore be included in a final set of recommenda-
tions? (b) Should any of the included elements be reformulated for the
EH SR context, and if so, how? (c) Were there any additional elements
that should be included for the EH SR context and, if so, how should
they should be formulated? (d) Were there questions for clarification
and follow-up? Further detail on the assumptions, methodological de-
cisions, and structure of the consensus process behind COSTER is pro-
vided in Supplement 02.
GB and CH took notes of the discussion in each group. Comments
were collated into a redrafted document and, in response to a request
by workshop participants, cross-checked by PW against the Campbell
Collaboration MEC2IR standard (Campbell Collaboration, 2014). This
was to check for any further possible elements that might be included as
recommendations in COSTER. The COSTER recommendations were
then discussed in a series of six one-hour webinars held between Jan-
uary and June 2017, chaired by PW and attended on average by six
participants (EA, ABe, RdV, KG, AH, NH, SH, CK, JL, OM, LR, AR, HS,
KS, DW, CH, TW participated in at least one). The webinars were fol-
lowed by email exchanges and bilateral phone calls between PW and
various authors to finalise wording and agree that consensus had been
reached.
The consensus process was closed by PW on 24 January 2018;
participating authors confirmed agreement with the consensus by
signing off as co-authors of this manuscript. Non-authoring contributors
are listed in the Acknowledgements.
The manuscript went through three rounds of journal peer-review,
during which the framing and implications of COSTER as a consensus
process and resulting set of good-practice recommendations were re-
vised and clarified. The most significant change was the reframing of
COSTER from a “code of practice” to a set of recommendations. While
the process followed in COSTER was intended to emulate formal stan-
dardisation processes, the peer-reviewers suggested the authors were
potentially over-reaching in describing what they had achieved, and
that the formal language of standardisation was an impediment to
communication of the core messages of the manuscript. The authors
therefore removed reference to formal standards, instead presenting
COSTER as a set of recommendations for good practice. The COSTER
recommendations themselves, as they were the result of the consensus
process, were not changed in peer-review. For transparency, previous
versions of the manuscript are archived on Zenodo.org (Whaley et al.,
2020).
3. Results
COSTER presents 70 recommendations for good practice in the
conduct of EH SRs, distributed across 8 steps of the SR process. If fol-
lowed, the recommendations should result in a EH SR having the fol-
lowing three characteristics which are considered, in the opinion of the
authors, as critical for the scientific quality of EH SR projects:
1. Utility: addressing an important research question and advancing
community understanding of an environmental health issue via a
methodology of synthesising existing research;
2. Transparency: encouraging comprehensive consideration of the as-
sumptions and methods employed in a SR such that, if they are
adequately reported, a reader is able to appraise the validity of the
SR’s findings and assess their relevance to a given decision-making
context;
3. Credibility: minimising the risk that a SR’s findings are biased either
by limitations in the evidence base itself or in the processes used to
locate and synthesise that evidence.
The eight COSTER domains cover the following methodological
elements of the SR process: planning the SR; searching for evidence;
selecting evidence for review; extracting data; critically appraising each
individual included study; synthesising the evidence; interpreting the
evidence and summarising what it means for the review question; and
drawing conclusions (see Fig. 2). The recommendations within each
domain are listed in Table 1. An explanation of key recommendations is
provided in Table 2. Guidance on how to use COSTER is presented in
the Discussion section of this manuscript.
In total, 20 of the 31 workshop participants, plus TW, signed off as a
manuscript author. Eight participants did not participate in the con-
sensus process beyond the workshop; they were not asked why, but
when reasons were given they related to restrictions imposed by the
governance policies of employing organisations in relation to
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employees’ endorsement of guidance documents, or a lack of personal
capacity to contribute to a lengthy process of discussion and manuscript
development. Only one participant who was involved in the develop-
ment of the manuscript itself ultimately felt they could not sign off as an
author, citing differences between COSTER and the official policies of
the organisation with which they were affiliated, and the potential for
confusion that might cause if their authorship was misinterpreted as
organisational endorsement. None of the participants opposed pub-
lication of COSTER.
4. Discussion
4.1. How to use COSTER
4.1.1. Target audience of COSTER
COSTER is intended to be usable by any entity or practitioner re-
sponsible for or interested in conducting an EH SR project, and who
needs a benchmark against which different possible approaches can be
evaluated. Such entities include: independent scientists; journal editors
receiving SR submissions; research teams wishing to conduct a SR; re-
search commissioners seeking confidence that a contractor will conduct
a successful SR project; quality assurance units in research-associated
organisations seeking to implement consistent, good-quality SR prac-
tices; and regulatory authorities and scientific agencies seeking to de-
monstrate compliance with an agreed set of practices for conduct of
research.
4.1.2. Managing the number of recommendations in COSTER
SRs are complex, multi-disciplinary projects that typically take
12–36 months to conduct (Borah et al., 2017; Haddaway and Westgate,
2019). While 70 may seem like a large number of recommendations for
a research team to follow, COSTER is comparable in size to IOM, which
consists of 82 performance elements across 4 domains, and MECIR 1.07,
which consists of 75 performance elements across 10 domains. COSTER
is intended to be used in parallel to the development, conduct, and
reporting of a systematic review in an iterative manner, which mirrors
many of the considerations that should naturally arise for research
teams undertaking each of these steps. Therefore, following COSTER’s
recommendations is unlikely to constitute an additional burden for a
well-designed and well-conducted SR. In other scenarios, COSTER
should help identify oversights and limitations in methods that might
threaten the integrity of a SR project.
4.1.3. How should adherence with COSTER be described?
When research teams report the use of COSTER in planning and
conducting a SR, they are encouraged to avoid broad summary state-
ments such as “COSTER was followed” or “we adhered to the re-
commendations of COSTER”. Although prevalent in the literature, such
self-reported statements are usually only partly true and may therefore
mislead the reader about the exact methods used (Page and Moher,
2017). Instead, authors should report that COSTER was used to inform
the planning and conduct of a SR, and transparently describe whether
and how they were able to respond to each recommendation. The re-
commendations are numbered to facilitate this process. Where re-
searchers elect to depart from COSTER, it is helpful if the reasons for
doing so are explained.
4.2. Comparing COSTER to other SR standards and guidelines
COSTER is the first explicit effort by EH research practitioners and
stakeholders to validate commonly-used biomedical SR standards for
their particular cultural and research context. Table 2 highlights key
explanatory points for COSTER according to themes that are either
unique to the context of EH research, address aspects of systematic
review conduct for which it has historically been difficult to achieve
consensus on recommended practice, are potentially controversial
given current SR practices in the field of EH, or provide a novel con-
tribution to progressing SR practices in general. Where COSTER closely
follows the conventions of IOM and MECIR, we refer the reader to Eden
et al. (2011) and Higgins et al. (2019) for detailed explanation as to
why the recommendations are considered good practice in SR.
4.3. Strengths and limitations of COSTER
4.3.1. The consensus process
In developing COSTER, a deliberate attempt was made to emulate
formal standardisation processes such as those followed by the British
Standards Institution. We made a particular effort to involve a full
complement of stakeholder groups in direct participation in the con-
sensus process. This was to ensure coverage of a wide range of potential
opinions as to what might constitute good practice in conduct of EH
SRs, which then needed to converge over time into a consensus view.
We are not aware of other research standards that have sought to do
this to the same extent: the IOM standards represented the views of a
committee of 16 medical professionals supported by a team of re-
searchers, while MECIR was developed by a dedicated Cochrane com-
mittee and finalised in response to stakeholder comments.
In the end, we were able to achieve consensus of 20 workshop
participants, plus TW. At least one representative from each of the
various stakeholder groups is represented in the authorship, the results
of which are a comprehensive set of 70 recommendations for good
practice in conduct of EH SRs. The recommendations cover complex
issues including protocol development, risk of bias, and certainty as-
sessment, which are inconsistently implemented across the EH SR lit-
erature.
In order to improve this consensus process, and to elevate COSTER
1.5 Publish protocol 
(4) 
1.4 Plan methods: 
search; selection; 
analysis; data sheets 
(7) 
1.3 Define eligibility 
criteria 
(9) 








search which does not 
exclude any relevant 
literature 
(7) 
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(4) 
Extract the relevant 
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in the review process 
(5) 
Assess limitations in 
design and conduct of 
included studies which 
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systematic error 
into their results 
(6) 
Generate all data which 
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describe and qualify 
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research question 
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Total number (n) of recommendations = 70 
Fig. 2. Conceptual structure of COSTER with objectives for each stage of the SR process.
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Table 1
The full list of COSTER recommendations for the planning and conduct of environmental health systematic reviews. The recommendations should be read alongside
the explanatory notes in Table 2.
COSTER v1.0.0: Recommendations for the planning and conduct of environmental health systematic reviews
1. Planning the Review and Preparing the Protocol
1.1 Securing capacity, competencies and tools 1.1.1 Ensure the review team has sufficient combined competence to conduct the systematic review, including relevant
expertise in: information science (for e.g. search strategies); evidence appraisal; statistical methods; domain or subject
expertise; systematic review methods.
1.1.2 Identify information management practices for each stage of the review, including reference and knowledge
management tools, systematic review software, and statistics packages.
1.1.3 Exclude people or organisations with apparent conflicts of interest relating to the findings of the review from analysis
and decision-making roles in the review process.
1.1.4 Disclose the roles and all potential conflicts of interest of all people and organisations involved in planning and
conducting the review, including all providers of financial and in-kind support.
1.2 Setting the research question to inform the scope of the
review (“problem formulation”)
1.2.1 Demonstrate the need for a new review in the context of the scientific value of the question, the importance to
stakeholders of the question being asked, and the findings of any pre-existing primary research and/or evidence syntheses.
1.2.2 Articulate the scientific rationale for each question via development of a theoretical framework which connects e.g.
the exposure to the outcomes of interest (or otherwise as appropriate given the objectives of the review).
1.2.3 For each research question to be answered by the review, prospectively define a statement of the research objective
in terms of one or more of the following components, selected as appropriate:
● Population (objects of investigation, i.e. the entities to which exposures or interventions happen)
● Exposure or Intervention (the administered change in conditions of the objects of investigation, to include timing,
duration and dose)
● Comparator (the group to which the intervention or exposure groups are being compared)
● Outcome (the change being measured in the intervention or exposure group)
● Study design (specific design features of relevant research)
● Target condition (the object of a test method for diagnosis or detection)
1.3 Defining eligibility criteria 1.3.1 Define and justify unambiguous and appropriate eligibility criteria for each component of the objective statement.
1.3.2 Define the points at which screening for eligibility will take place (e.g. pre-screening based on title/abstract, full text
screening, or both)
1.3.3 For interventions, exposures and comparators: define as relevant to review objectives the eligible types of
interventions and/or exposures, methods for measuring exposures, the timing of the interventions/exposures, and the
interventions/exposures against which these are to be compared.
1.3.4 For outcomes: define as relevant to review objectives the primary and secondary outcomes of interest (including
defining which are apical and which are intermediate), what will be acceptable outcome measures (e.g. diagnostic criteria,
scales) and the timing of the outcome measurement.
1.3.5 For study designs: define eligible study designs per design features rather than design labels.
1.3.6 Include all relevant, publicly-available evidence, except for research for which there is insufficient methodological
information to allow appraisal of internal validity.
1.3.7 Include evidence which is relevant to review objectives irrespective of whether its results are in a usable form.
1.3.8 Include relevant evidence irrespective of language.
1.3.9 Exclude evidence which is not publicly available.
1.4 Planning the review methods at protocol stage 1.4.1 Design sufficiently sensitive search criteria, so that studies which meet the eligibility criteria of the review are not
inadvertently excluded.
1.4.2 Design “characteristics of included studies” table.
1.4.3 Define the risk of bias assessment methods to be used for evaluating the internal validity of the included research. If
observational studies are included, this should cover identification of plausible confounders.
1.4.4 Design the methods for synthesising the included studies, to cover: qualitative and quantitative methods (with full
consideration given to synthesis methods to be used when meta-analysis is not possible); assessment of heterogeneity;
choice of effect measure (e.g. RR, OR etc.); methods for meta-analysis and other quantitative synthesis; pre-defined,
appropriate effect modifiers for sub-group analyses.
1.4.5 Define the methods for determining how, given strengths and limitations of the overall body of evidence, confidence
in the results of the synthesis of the evidence for each outcome is to be captured and expressed. (For reviews which include
multiple streams of evidence, this may need to be defined for each stream.)
1.4.6 For reviews which include multiple streams of evidence (e.g. animal and human studies), define the methods for
integrating the individual streams into an overall result. This should include a description of the relative relevance of
populations (e.g. species, age, comorbidities etc.), exposures (e.g. timing, dose), and outcomes (direct or surrogate, acute
or chronic model of disease, etc.), as appropriate, per which inferences about predicted effects in target populations can be
made from observed effects in study populations.
1.4.7 Pilot-test all components of the review process in which reviewer performance could affect review outcomes. This
includes the design and usability of the data extraction form/s, and the conduct of the risk of bias assessment.
1.5 Publishing the protocol 1.5.1 Create a permanent public record of intent to conduct the review (e.g. by registering the protocol in an appropriate
registry) prior to conducting the literature search.
1.5.2 As appropriate for review planning and question formulation, secure peer-review and public feedback on a draft
version of the protocol, incorporating comments into the final version of the protocol.
1.5.3 Publish the final version of the protocol in a public archive, prior to screening studies for inclusion in the review.
1.5.4 Clearly indicate in the protocol and review report any changes in methods made after testing or conduct of any steps
of the review.
(continued on next page)
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Table 1 (continued)
COSTER v1.0.0: Recommendations for the planning and conduct of environmental health systematic reviews
2. Searching for Evidence
2.1 Search all the key scientific databases for the topic, including national, regional and subject-specific databases.
2.2 Define reproducible strategies for identifying and searching sources of grey literature (databases, websites etc.).
2.3 Structure search strategies for each database, electronic and other source, using appropriate controlled vocabulary,
free-text terms and logical operators in a manner which prioritises sensitivity.
2.4 Search within the reference lists of included studies and other reviews relevant to the topic (“hand-searching”) and
consider searching in the reference lists of documents which have cited included studies.
2.5 Search by contacting relevant individuals and organisations.
2.6 Document the search methods and results in sufficient detail to render them transparent and reproducible.
2.7 Re-run all searches and screen the results for potentially eligible studies within 12 months prior to publication of the
review (screening at least at the level of title plus abstract). In deciding whether to incorporate new studies in the review,
the importance of a possible change in results should be weighed against any delay in publication. Potentially eligible
studies which have not been incorporated should be listed as “awaiting classification”.
3. Screening Evidence for Inclusion
3.1 Screening of each piece of evidence for inclusion to be conducted by at least two people working independently, with
an appropriate process (e.g. third-party arbitration) for identifying and settling disputes.
3.2 Document decisions in enough detail to allow presentation of the results of the screening process in a PRISMA flow
chart.
3.3 Studies which are excluded after assessment of full text should be listed in a table of excluded studies along with the
reason for their exclusion (one reason is sufficient).
3.4 Do not exclude multiple reports of the same research (e.g. multiple publications, conference abstracts etc.); instead
collate the methodological information from each of the reports as part of the data extraction process for each unit of
evidence.
4. Extracting Relevant Data from Included Study Reports
4.1 Collect characteristics of the included studies in sufficient detail to populate the planned “characteristics of included
studies” table.
4.2 Extraction of study characteristics and outcome data to be conducted by at least two people working independently
with an appropriate process (e.g. third-party arbitration) for identifying and settling disputes.
4.3 Assessment of risk of bias to be conducted separately from data extraction. Ideally, and where appropriate, risk of bias
assessment should be conducted between extraction of study characteristics and extraction of outcome data (study results).
4.4 Correct for errors and omissions in data reported in included studies by: (1) collecting the most detailed numeric data
possible; (2) examining relevant retraction statements and errata for information; (3) obtaining where possible relevant
unpublished data which is missing from reports and studies.
4.5 Check accuracy of the numeric data in the meta-analysis utilising an appropriate process (e.g. third-party control).
5. Appraising the Internal Validity of Included Studies
5.1 Appraise internal validity of each included study via the risk of bias assessment methodology specified in the protocol.
5.2 Assess risk of bias per outcome or outcome-exposure pair (as appropriate) rather than per study.
5.3 Risk of bias assessment is to be conducted by at least two people working independently, with an appropriate process
(e.g. third-party arbitration) for identifying and settling disputes.
5.4 Apply the risk of bias assessment tool thoroughly and consistently to each included study, recording each risk of bias
judgement made by each reviewer, and any disagreements and how they were resolved.
5.5 If there is empirical evidence which supports a judgement, comment but do not guess on likely direction and (if
possible) magnitude of effect of bias.
5.6 Provide appropriate explanation for judgement of risk of bias, making reference to decision processes described in the
protocol, and using supporting quotes from study reports or noting if information was not available.
6. Synthesising the Evidence/Deriving Summary Results
6.1 Undertake (or display) meta-analyses only when studies are sufficiently comparable as to render the combined result
meaningful.
6.2 Transform all scales (where appropriate) into common measures of outcome, explaining how each scale has been
reinterpreted in the review.
6.3 Use appropriate methods to assess the presence and extent of between-study variation (statistical heterogeneity) when
undertaking a meta-analysis.
6.4 If important statistical heterogeneity is observed, explain how this is accommodated in developing appropriate
summary results for the review (e.g. by not pooling at all, by conducting subgroup analyses etc.)
6.5 Assess the potential for publication bias in the data (i.e. systematic differences between the evidence which was
accessible to the review, and the evidence which was not).
6.6 Assess potential impact of risk of bias in the synthesis, based on the results of the appraisal of risk of bias in the
included studies (e.g. sub-group analysis excluding studies at high risk of bias; appropriate qualitative or quantitative
approaches).
6.7 Test the robustness of the results using sensitivity analyses (such as the impact of notable assumptions, imputed data,
borderline decisions and studies at high risk of bias).
6.8 If subgroup analyses are conducted, follow the subgroup analysis plan specified in the protocol, avoiding over-
interpretation of any particular findings; sensible post-hoc analyses may also be carried out.
(continued on next page)
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from a set of expert recommendations towards a more formal standard
such as a Code of Practice (BS EN ISO 9001:2015; BS EN ISO
9000:2015), we suggest the following potential actions: securing
greater capacity to organise and participate in more face-to-face
meetings; a longer process involving more stakeholders to potentially
allow for broader consensus on some of the more challenging or con-
troversial discussions, covering more elements of the SR process; and
implementation of more formal minute-taking and communication
structures for making the consensus process more auditable, improve
transparency, and facilitate communication between participants in the
consensus process.
4.3.2. Author conflicts of interest
In order to secure cross-sector consensus, we purposely invited
participants with varied interests in relation to developing a standard
for conduct of EH SRs. We did not attempt to directly manage the in-
terests of participants, as they were seen as desirable; instead, we
sought balance across stakeholder groups and domains of expertise. We
believe involvement of a broad cross-section of stakeholder groups
strengthens COSTER’s generalisability and broadens its acceptability,
while reducing the risk that any individual interest group has had ex-
cess influence on the consensus outcome.
4.3.3. The process for developing seed recommendations for COSTER
Rather than conduct a SR of existing standards and guidance of
potential relevance to seed the development of COSTER, we relied on
participants’ tacit knowledge of these in critiquing two established
biomedical standards for SR practice. We secured participation of sta-
keholders with experience developing the following frameworks: the
Navigation Guide (Woodruff and Sutton, 2014), the National Tox-
icology Program Office of Health Assessment and Translation (Rooney
et al., 2014); SYRINA (Vandenberg et al., 2016); the European Food
Safety Authority (EFSA, 2010); Cochrane’s MECIR standards and the
Cochrane Handbook (Higgins et al., 2011); GRADE (Morgan et al.,
2016); the IARC Monographs Program (IARC, 2015); and SYRCLE
(Vries et al., 2015).
MECIR and IOM, as seeds for COSTER, were selected as author-
itative standards likely to be comprehensive and not misleading in ei-
ther what they include or omit. These two existing standards provided
80 seed criteria (see Supplemental Materials 03). While a SR of existing
standards and guidelines could have extended this list, we believe it
would have been a considerable task to undertake without obvious
proportional benefit to a project which sought to define an initial expert
consensus on basic recommended practices in EH SR. This is an element
of the COSTER development methodology which could certainly be
improved in future; a detailed discussion of this follows in Section 4.4
below.
4.3.4. Potential for misuse of COSTER
The value of all SRs is diminished by misuse of the term “sys-
tematic” and the publication of poor-quality SR manuscripts. COSTER
seeks to avert this situation by giving authors, reviewers, editors and
other stakeholders clear, comprehensive recommendations on the fun-
damental practices of SR. At the very least, by providing an un-
ambiguous set of recommendations against which the conduct of a
putative SR can be compared, the authors hope that it will be easier for
the user to identify when phrases such as “adheres with the re-
commendations of COSTER” and “employed systematic review
methods” are being misused.
In general, the authors recommend that readers be cautious in
making any assumptions about the quality of a SR which uses or claims
to have complied with COSTER. While COSTER is intended to help
authors make good decisions about their EH SR methods, as a written
document it has little power on its own to ensure they have been
Table 1 (continued)
COSTER v1.0.0: Recommendations for the planning and conduct of environmental health systematic reviews
7. Interpreting Results
7.1 Interpret the internal validity of the overall body of evidence by considering results of the appraisal of internal validity
(risk of bias) of each included study. The review should describe the potential for biased summary results due to
limitations in study design and conduct (e.g. extent of randomisation, blinding, confounding etc.) and the implications of
these limitations for drawing conclusions based on the overall body of evidence.
7.2 Interpret the consistency of the overall body of evidence, accounting for explainable and unexplainable variation
between studies. If a meta-analysis has been conducted, consider statistical heterogeneity. Where appropriate, conduct
sub-group and sensitivity analyses.
7.3 Interpret any subgroup analyses without selective reporting of results or placing undue emphasis on specific findings.
7.4 Interpret the precision of the results of any syntheses, taking care to interpret statistically non-significant results as
findings of uncertainty rather than no effect, unless the confidence intervals are sufficiently narrow to rule out an
important magnitude of effect.
7.5 Interpret the magnitude of the observed effect.
7.6 Interpret the dose–response relationship in the observed results.
7.7 Interpret the potential effects of reporting and publication biases (e.g. unreported outcome data, unpublished studies
etc.) on the observed results.
7.8 Interpret the external validity of the overall body of evidence. Any inferences or predictions about effects in target
populations which are made based on effects observed in the populations in the included studies should accord with the
considerations defined in the protocol about the relative relevance of populations (e.g. species, age, comorbidities etc.),
exposures (e.g. timing, dose), and outcomes (direct or surrogate, acute or chronic model of disease, etc.), as appropriate.
Deviations from these considerations must be explained and justified.
7.9 Include the “summary of findings” table.
7.10 Summarise the quality of the overall body of evidence into an appropriate overall statement of confidence in the
results of the synthesis.
8: Drawing Conclusions
8.1 Draw out implications based only on findings from the synthesis of studies included in the review.
8.2 Describe implications for research based on Population-Exposure-Comparator-Outcome or other appropriate formula
consistent with that specified in the research objective.
8.3 Avoid describing policy implications in terms of specific actions authors feel that decision-makers should take. If
authors feel it is necessary to describe policy implications, articulate them in terms of hypothetical scenarios rather than
making specific policy recommendations.
P. Whaley, et al. Environment International 143 (2020) 105926
7
Table 2
Explanation and elucidation of key recommendations of COSTER.
Explanation and elucidation of key recommendations of COSTER v1.0.0
Project planning: recommendations 1.1.1 through 1.5.4
Contribution of COSTER: Emphasis on
importance of standard practices in biomedical
SRs for environmental health research
COSTER recommends conducting EH SRs according to pre-published protocols. Following a pre-published protocol can
reduce the risk that changes in methods mid-project will bias the results of a SR, by enabling comparison of the completed
review with what was planned in the protocol (Centre for Reviews and Dissemination, 2020). Protocol publication also
provides an opportunity for external peer-review of proposed methods and subsequent early identification of errors which, if
left unresolved, could undermine the validity of a resource-intensive project (Munafò et al., 2017).
Although not yet common practice, some EH SRs are being conducted according to pre-published protocols – see e.g.
Mandrioli et al. (2018), Matta et al. (2019), and Hansen et al. (2019). COSTER follows MECIR and IOM in providing
comprehensive recommendations for the planning and protocol phase of a SR.
Disclosure and management of interests: recommendations 1.1.3, 1.1.4
Contribution of COSTER: Distinction between
potential and apparent conflicts of interest
relating to team selection in SRs
COSTER recommends defining a conflict of interest (COI) as “a situation in which financial or other personal considerations
would be considered by a reasonable person to have the potential to compromise or bias professional judgment and
objectivity”, and classifying COIs in two categories. These are: “apparent” conflicts of interest, defined as situations “in which
a reasonable person would think that the professional’s judgment is likely to be compromised”; and “potential” conflicts of
interest, which are situations “that may develop into an apparent conflict of interest”. This follows the Columbia University
framework for “Responsible Conduct of Research” (Columbia University, 2004).
The authors believe this approach offers a way to operationalise the description and handling of risks that COIs pose to the
integrity of a SR project. Firstly, all interests are declared. Then, the classification of “potential” is applied to any interest for
which the degree of conflict is unlikely to present a risk to the integrity of the project, while the classification of “apparent” is
applied to any interest for which the degree of conflict may present excess risk to the integrity of the project. Persons with
apparent conflicts of interests are excluded from involvement in decision-making processes.
COSTER allows for interests to be financial and non-financial. Similar to IOM, COSTER recognises that any potential COI can,
in the right circumstances, become an apparent COI, and that all potential COIs should therefore be declared, evaluated and
managed. COSTER distinguishes itself from the IOM approach to COIs by emphasising that individuals with apparent
conflicts of interest need only be excluded from analysis and decision-making roles in the review process. This leaves open
the possibility of their involvement in advisory capacity as individuals with specialist knowledge on which review teams can
draw, while insulating the integrity of the review process from their apparent COIs by prohibiting their involvement in
decision-making. This allows EH SRs to utilise the full range of expertise in a field in which many practitioners will likely
have apparent COIs.
The authors emphasise that the intent of these recommendations is not to limit participation in EH SRs by excluding people
with affiliation to broad sectors (e.g. academic grant holders, industry, or NGOs), but rather to make such associations
transparent. In lieu of declaration of interest forms built specifically for environmental health research, SR authors could
consider using forms such as those published by the International Committee of Medical Journal Editors (International
Committee of Medical Journal Editors, 2013).
Interpreting external validity of the evidence, and integrating multiple evidence streams: recommendations 1.2.2, 1.4.6, 7.8
Contribution of COSTER: Adaptation of
biomedical SR standards to specific context of
EH research
Operationalising the interpretation of indirect, non-human and in vitro evidence in the course of predicting health risks in
target human populations is a fundamental challenge in adapting SR methods to environmental health. For healthcare
interventions, IOM specifies the use of an “analytical framework which clearly lays out the chain of logic that links the health
intervention to the outcomes of interest”. COSTER applies this concept in its recommendations for the assessment of the
external validity of evidence, to account for the importance in EH research of consistent, unbiased interpretation of an
evidence base which is often indirect.
EH researchers are increasingly interested in how the analysis of indirect mechanistic evidence can be organised via
predictive biological networks (Villeneuve et al., 2014b, 2014a) or Key Characteristics frameworks (Smith et al., 2016;
Arzuaga et al., 2019; Luderer et al., 2019) to help anticipate whether an environmental challenge will cause an adverse
health outcome.
In anticipation of the development of systematic approaches to developing and assessing the plausibility of such networks
or framework analyses, in recommendation 1.2.2 COSTER asks that protocols include the basic elements of a theoretical
framework for interpreting the external validity of included studies. The framework should describe why and to what
extent the review team will consider different populations (e.g. species, developmental stage), exposures (e.g. timing, dose,
similarity of substance/read-across) and outcomes (e.g. apical, intermediate) to be comparable to the target populations,
exposures and outcomes of interest. Recommendation 7.8 asks that interpretation of the results of synthesis are made in
accordance with this pre-specified framework.
Formulation of research objectives: recommendations 1.2.3, 1.3.3, 1.3.4, 1.3.5, 1.3.9
Contribution of COSTER: Formal clarification of
use of PECO-style statements in formulating SR
objectives in EH research
COSTER recommends formulating SR objectives in a structured format using context-appropriate elements of the PECOTS
(Population-Exposure/Intervention-Comparator-Outcome-Target Condition-Study Design) mnemonic. SRs that investigate
health effects of exposures and interventions (such as amelioration of the effects of exposures) are both expressly allowed for
in COSTER.
COSTER also makes granular recommendations about the specific aspects of the PECOTS elements that should be
considered in establishing the objectives of an EH SR. Because elements such as timing of exposure are a potentially critical
issue in reliably identifying health risks of environmental exposures, COSTER recommends these be considered and defined
as necessary. Specific guidance on good practice in the formulation of PECO statements by Morgan et al. (2018) has been
published since the COSTER recommendations were finalised, to which prospective authors may wish to refer.
(continued on next page)
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Table 2 (continued)
Explanation and elucidation of key recommendations of COSTER v1.0.0
Including informally published or previously unpublished literature, regardless of usability in the planned analysis: recommendations 1.3.6 to 1.3.9, 3.4
Contribution of COSTER: Provides unambiguous
rationale for exclusion of study reports due to
insufficient information content
COSTER recommends that grey literature (i.e. studies that have not been published in peer-reviewed journals) should be
included in systematic reviews. This is because the relevance of evidence is determined by the SR objectives, not by the
publication status of that evidence, the language the evidence is in, nor its compatibility with the analyses planned by the
reviewers.
The inclusion of grey literature can act as a safeguard against the influence of publication bias; however, researchers should
never assume that the grey literature which can be located is representative of the grey literature overall. The authors of
COSTER also acknowledge that inclusion of grey literature can be daunting and for some SR authors may be controversial
(Adams et al., 2016; Paez, 2017). Therefore, COSTER provides an explicit rationale for where researchers can draw the line
on including grey literature in a SR, as follows.
Firstly, in keeping with the SR principle of transparency, COSTER recommends that only publicly available information
about a study be eligible for inclusion (recommendation 1.3.9). The authors note that a SR that brings into the public domain
previously inaccessible information can be the mechanism by which such data becomes publicly accessible and therefore
eligible for inclusion. This has happened with SRs from WHO (Descatha et al., 2018; Li et al., 2018) and Cochrane (Jefferson
et al., 2014).
Secondly, COSTER recommends exclusion of studies for which there is insufficient information for risk of bias to be
evaluated, to prevent the inclusion in a SR of evidence that is potentially misleading but cannot be identified as such by the
reviewers (recommendation 1.3.6).
Thirdly, COSTER defines the included study itself, not documents describing the study, as the unit of evidence
(recommendation 3.4). Therefore, COSTER recommends all publicly accessible study documents including conference
abstracts etc. be gathered and assessed for information content as a whole, before a decision is made to exclude a study in
accordance with recommendation 1.3.6. Researchers should take care not to double-count populations when combining
multiple study reports, particularly when there is partial overlap between multiple documents.
Fourthly, COSTER recommends that documents should be included in a SR regardless of whether their data fit the analysis
plan of the reviewers or they are in a language in which the reviewers are fluent. This is to ensure that study documents
which may contain information of potential relevance to the SR’s research objectives are not excluded from the data
extraction step of the SR.
The authors are aware that many studies – especially epidemiological studies – cannot release detailed information on
individual participants owing to privacy concerns and legal mandates. The intent of the grey literature recommendations in
COSTER is not to exclude such studies, but rather to ensure that the use of study-specific findings within the larger analysis
is supported by those aspects of the underlying data that are available for public scrutiny.
Protocol publication: recommendations 1.5.1, 1.5.2, 1.5.3
Contribution of COSTER:Contribution of
COSTER: Differentiates between protocol
registration and publication as distinct steps of
the methods development process
Protocol registries such as PROSPERO (Centre for Reviews and Dissemination) and preprint repositories such as Zenodo
(CERN) and the Open Science Framework (Center for Open Science, 2020) allow authors to register their methods in advance
of conducting a SR. However, there are no protocol registries that ensure authors have submitted sufficient information about
methods that a reader can be confident a registered protocol is a complete plan for conducting a SR. Nor do such registries
have capacity to peer-review protocols for soundness of the proposed methods. At most, they perform only basic quality
control checks. This leads to a situation in which the value of self-registration for ensuring the comprehensiveness and
validity of methods for a given protocol is unclear. Therefore, it is the view of the authors that self-registration of a protocol
has value primarily as a record of intent to conduct a SR, rather than serving as a guarantee of comprehensive documentation
of methods prior to conduct of a SR.
To address the limitations of protocol registration, COSTER recommends that authors of SRs take a two-step approach to
protocol publication. As the first step, an outline of the proposed SR with the minimum necessary information to
characterise objectives and approach should be posted on an appropriate public registry or functional equivalent thereof,
over which the authors have no direct control (recommendation 1.5.1). This first draft is the permanent public record of
intent to conduct a systematic review, functioning to communicate research aims and help other review teams avoid
planning duplicate SRs. As the second step, this draft can then be developed in further detail as a full protocol submitted to
external peer-review or other appropriate quality management process (recommendation 1.5.2), and then published either
in a scientific journal or a preprint repository (recommendation 1.5.3). An example of journal publication of a protocol is
provided by Mandrioli et al. (2018) and in a public repository by Martin et al. (2018). A general example of this kind of
“two-stage” peer-review process, to which readers may wish to refer, is provided by the Registered Reports model of
scientific publication (Chambers, 2019).
Assessing the internal validity of included studies: recommendations 1.4.3, 5
Contribution of COSTER: Explicit specification of
risk of bias methods for assessing internal
validity of included studies
To prevent systematic errors in included studies being transmitted through to the findings of a SR, COSTER recommends that
each included study be assessed for internal validity, i.e. its potential to produce biased results. While anticipating direction
and magnitude of bias is desirable in assessing the internal validity of included studies, this is often not possible or practical
for SR projects; however, when feasible, evidence-based assessments of internal validity, which successfully quantify bias are
consistent with COSTER.
COSTER makes no specific recommendations about which instruments should be used to assess risk of bias, leaving it to SR
authors to determine which methods are best-suited to their research objectives. COSTER does, however, make a number of
recommendations about the process of risk of bias assessment. This includes assessing risk of bias per outcome
(recommendation 5.2) and making sure each judgement is transparent and grounded in the reviewed text (recommendation
5.6).
There is concern that risk of bias instruments may be misapplied in EH SRs, resulting in mischaracterisation of the validity
of included studies (Farrah et al., 2019). The authors note that risk of bias assessment methods need to be sensitive to
differences in study designs and employ suitable processes accordingly. The assessment process should balance being
transparently conducted against a clear standard, whilst ensuring that potential limitations of a study are not
mischaracterised by algorithmic comparison to inappropriately rigid validity criteria. Various systematic reviews and
evaluations of risk of bias assessment tools are available (e.g. Wang et al., 2019; Krauth et al., 2013; Rooney et al., 2016)
and a user of COSTER may wish to refer to such in deciding which tools to apply in a SR.
(continued on next page)
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successful in making them. As is the case for any standard or set of
recommendations, claims of following COSTER are open to potential
abuse, either deliberate or inadvertent, as a mechanism for artificially
elevating a reader’s perception of the quality of a piece of research. A
SR should therefore always be appraised using a valid, contextually
appropriate tool before coming to any judgments about its quality.
4.4. Future development of COSTER
The recommendations of COSTER are intended as a first step in a
broader research and consensus-building process, which it is hoped will
eventually yield a robust, international standard for conduct of sys-
tematic reviews in environmental health research. Formal standards are
typically based on both expectation and empirical evidence that the
practices described in the standard contribute to a product or process
being fit for purpose, combined with broad acceptance of the practices
among the community that is expected to adopt the standard. Since SR
methods are still relatively new in environmental health research, it
follows that while the consensus view of small groups of experienced
practitioners as to what they consider good practice can be secured, this
view is unlikely to be universally shared; nor is strong evidence for
what is effective practice necessarily going to be available. This is
particularly true for areas in which SR methods are not readily portable
from social science and medical contexts to environmental health, or
where environmental health researchers face challenges not en-
countered in other fields. Broad consensus is also a challenging goal
when only a small, albeit growing, part of the community is employing
SR methods in conducting reviews of evidence, and practices across
those SRs are inconsistent. While COSTER represents the consensus
view of the authors, other expert groups may disagree with some of the
recommendations of COSTER. Such disagreement is healthy: by making
explicit a set of key recommended practices for SR, COSTER serves as a
focal point for discussion and advancing consensus across groups.
As community experience in conducting EH SRs develops over the
next period, the authors suggest that future development of COSTER
adopt the framework for development of reporting guidelines for health
research presented in Moher et al. (2014). This framework emphasises
four steps:
1. a systematic review of existing standards and guidelines;
2. a systematic review of the prevalence of current research practices;
3. the critical appraisal of existing guidelines and current research
practices for completeness, face validity, and construct validity;
4. a process to determine community consensus on best practices and
the criteria for a guideline.
Steps 1 and 2 would result in a larger seed-set of potential re-
commendations than was provided by selecting the MECIR and IOM
standards as the basis for the current consensus. However, such a SR
could be a significant undertaking, as it requires a decision as to what is
relevant (e.g. should nutrition and public health standards be in-
cluded?) and potentially interpreting the implied standards in several
large handbooks, a large number of reporting standards and guidelines,
and potentially even individual SR study reports as well. This is a major
challenge for qualitative analysis and requires appropriate resources.
Steps 3 and 4, as a broad discussion and consensus process, would
provide a community view of where current practices fall short of ex-
pectation or need, or where specific processes might exceed what the
community views as strictly necessary for conduct of a robust EH SR.
For future versions of COSTER, it is important that the consensus
Table 2 (continued)
Explanation and elucidation of key recommendations of COSTER v1.0.0
Assessment of confidence or certainty in the overall body of evidence: recommendations 1.4.5, 7.1, 7.2, 7.4, 7.5, 7.6, 7.7, 7.8, 7.10
Contribution of COSTER:Contribution of
COSTER: Emphasis on evaluation of quality of
evidence against pre-specified criteria known to
be of importance when assessing confidence in
the results of a SR
COSTER recommends that assessment of overall confidence in the evidence included in a SR cover seven characteristics:
internal validity, consistency, precision, magnitude of effect, dose–response relationship, reporting and publication bias, and
external validity. While these are the same broad characteristics as those utilised in the GRADE Framework (Guyatt et al.,
2008; Guyatt et al., 2011), COSTER makes no specific recommendations about which tool should be used for assessing these
characteristics nor how they should be interpreted, except that the approach should be described in the SR protocol.
Appropriate methods for assessing confidence in the results of an EH SR are a matter of ongoing discussion. The GRADE
Framework is under active development for the environmental health context (Morgan et al., 2016; Morgan et al., 2019). A
close interpretation of GRADE has been applied to environmental health questions in SRs by NTP OHAT (Rooney et al., 2014;
National Toxicology Program, 2016) and the Navigation Guide (Woodruff and Sutton, 2014; Johnson et al., 2016). The US
EPA IRIS Program, in a recent series of epidemiology and toxicology SRs (Radke et al., 2018; Radke et al., 2019) employed a
certainty assessment framework that utilises similar concepts as to those recommended in COSTER. The authors believe that
a systematic approach to assessing confidence in a body evidence is a fundamental part of the SR process because readers of a
SR need a trustworthy analysis of the overall trustworthiness of the evidence. The authors also note that a high-quality SR of
low-quality evidence is still a trustworthy SR – even if the SR process has shown that the reader cannot necessarily put much
trust in the evidence itself.
Making policy recommendations: recommendation 8.3
Contribution of COSTER: Emphasises that
recommendations about interventions are often
beyond the scope of a SR of health effects from
environmental exposures
The development of environmental health policy needs to account for a wide range of issues relating to evidence of health
risks, due political process, and the values and preferences of stakeholders affected by the policy. In contrast, systematic
reviews ask focused questions that typically respond to only one or two of the full set of issues of importance for policy
development. This is especially true for SRs of health effects of environmental exposures: while they address potential causes
of adverse health outcomes (i.e. are aetiological), they would not normally also investigate evidence for the effectiveness of
interventions aimed at mitigating those adverse outcomes.
While identifying threshold limits to inform policy decisions is often the core business of many EH SRs, COSTER adheres to
the principle that the conclusions of a SR should not reach beyond the evidence that was included within it. COSTER
therefore recommends authors resist answering questions about how best to mitigate the effects of an exposure or achieve a
risk threshold unless the SR has been designed to systematically locate, appraise and synthesise the relevant evidence for
providing such answers.
The authors note, however, that SRs characterising adverse outcomes from environmental exposures are often conducted to
support policy decisions. COSTER therefore recommends that when authors present policy implications of their SR, they do
so in the form of hypothetical frameworks. This means authors should state that if certain described conditions obtain, then a
given intervention may be effective for mitigating harm. Any assumptions the authors make about values, other evidence and
potential consequences of a decision should be made explicit as part of that hypothetical framework.
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process be extended beyond the 21 people it was possible to involve
here. Care will need to be taken to maintain stakeholder balance as
numbers of participants are increased.
The authors recommend COSTER be re-assessed according to the
above methodology, with a view to an updated set of recommendations
being published around 2025. Some examples of recent methodological
innovations in EH SR which should be considered for inclusion in future
versions of COSTER include:
● more detailed recommendations for handling of specific types of
evidence, including mechanistic and in vitro study designs, ob-
servational studies and controlled trials in humans;
● the handling of evidence of the efficacy of EH interventions, an
example of which being the health benefits from introducing low-
smoke cookstoves (e.g. Quansah et al., 2017);
● more advanced evidence integration techniques such as triangula-
tion (e.g. Lawlor et al., 2016) and meta-regression (e.g. Phung et al.,
2017);
● the prespecification of exposure assessment criteria in risk of bias
assessment, where COSTER currently only explicitly mentions con-
founders;
● more detailed recommendations for appraising the external validity
of included studies.
5. Conclusion
COSTER presents the recommendations of a diverse group of expert
practitioners, reflecting their consensus view on good practice in the
planning and conduct of environmental health systematic reviews.
COSTER is intended as the first step in a broader consensus-building
process which should lead to the eventual development of robust
standards for conduct of EH SRs, while in the near-term providing re-
commendations on good practice as guidance for EH SR stakeholders.
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